Zormapatide
Zormapatide is a gastric inhibitory polypeptide (GIP) receptor agonist peptide. Zormapatide contains 2-methylalanine residues and an N6-[N-(19-carboxynonadecanoyl)-L-γ-glutamyl-L-lysyl] modification. Zormapatide is applicable to the research of diabetes and metabolic diseases.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3056608-43-3
- Formule: C209H326N48O58
- Masse moléculaire:4439.11
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
As a GIP receptor agonist, Zormapatide activates GIP receptor-related signaling, and is used for in vitro studies of GIP receptor function and glucose metabolism regulation[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 3056608-43-3
-
Masse moléculaire 4439.11
-
Formule C209H326N48O58
-
Sequence
Tyr-{Aib}-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Lys-Ala-Leu-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-{Lys(Lys-Glu-CO-C18-COOH)}
-
Sequence Shortening
Y-{Aib}-EGTFISDYSKALDKIHQQDFVNWLLAQKGK-{Lys(Lys-Glu-CO-C18-COOH)}
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)